In May 2026, a new initiative will launch to accelerate product development for infectious diseases: the InFECT-TT Programme, together with the associated Infectious Diseases Innovation Fund. This initiative is implemented under the umbrella of InFECT-NL and contributes to the pandemic preparedness of the Netherlands.
InFECT-TT supports researchers in further developing promising academic ideas towards a startup or clinical application. Five university medical centres collaborate in this programme: Amsterdam UMC, LUMC, UMC Utrecht, Radboudumc, and UMC Groningen.
Together, they combine expertise in infectious diseases, valorisation, and venture building. The programme works closely with the Samenwerking Infectieziekten, an initiative of the NVMM (Dutch Society for Medical Microbiology), NVII (Dutch Society of Internal Medicine
Infectious Diseases) and the SGF (Association of Collaborating Health Foundations).
Researchers can apply for vouchers for validation, proof of concept, market exploration, and business development. Up to €57,000 is available per innovation, along with guidance from experienced business developers.
The Infectious Diseases Innovation Fund (IDIF) invests in early-stage startups with investments of up to €1.5 million. An independent fund manager (LEH) is responsible for this. The fund supports preclinical and early clinical development and helps companies apply for potential follow-on funding.
The focus is on therapies, vaccines, and platform technologies for infectious diseases. Diagnostics fall outside the scope of these initiatives. The InFECT-TT programme starts in May 2026 with the establishment of procedures and application conditions for vouchers.
For more information, see FAST.nl. You can subscribe for updates via the InFECT-NL newsletter.
Related news items
Radboudumc Investment Day keeps growing
11 October 2024Scientists, entrepreneurs and investors from the life sciences & health sector came together to exchange knowledge, network and talk about new collaborations.
go to page
Third Radboudumc Investment Day again well-attended
16 October 2023On October 12, the Radboudumc Investment Day took place for the third time. Scientists, entrepreneurs and investors from the life sciences & health sector came together in the Radboudumc Experience Center to exchange knowledge, network and talk about new collaborations.
go to page
Boosting the startup ecosystem in Nijmegen!
22 June 2023TechleapNL, Radboud university, Radboudumc and the municipality of Nijmegen hosted a successful event where innovative health and hightech startups shared their view on the challenges and opportunities for the local startup ecosystem.
go to page
Meet Healthy Ideas, Healthy Returns
2 June 2023Do you have a golden idea to improve healthcare, but not the resources to realize it? Discover Healthy Ideas, Healthy Returns: a Benelux-wide public-private network offering opportunities for healthcare investments and propositions, among other things.
go to page
Cell4Pharma successfully closed a major funding round
25 May 2023Radboudumc spin-off Cell4Pharma is pleased to announced it has successfully closed a major funding round, marking a significant milestone in their journey towards developing ciPTEC as the leading platform to study human renal biological interaction during the preclinical stages of drug development
go to page